Eloxx Pharmaceuticals Reports Third Quarter 2021 Financial and Operating Results and Provides Business Update

NEXT STORY
Immunocore presents new data on tebentafusp in metastatic cutaneous melanoma (mCM) and uveal melanoma (mUM) at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
PREV STORY
The Worldwide Biosimilars Industry is Expected to Reach $44.7 Billion by 2026
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Scopus BioPharma to Adjourn 2021 Annual Meeting of Stockholders

author_avatar
NASDAQ Market News

ArQule Reports Fourth Quarter and Full Year 2015 Financial Results

Conference Call Scheduled Today at 9:00 a.m. ET BURLINGTON, Mass., Feb. 29, 2016 (GLOBE ...

author_avatar
NASDAQ Market News

Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant Ovarian Cancer

author_avatar
NASDAQ Market News